Current studentsExisting staffContact us
 

Opportunities for deprescribing statins in patients with poor cancer prognosis

Simple item page
dc.contributor.authorTurner, J.
dc.contributor.authorSinghal, N.
dc.contributor.authorBell, J.S.
dc.date.issued2013
dc.identifier.citationJournal of Palliative Medicine, 2013; 16(11):1328-1328
dc.identifier.doi10.1089/jpm.2013.0278
dc.identifier.issn1096-6218
dc.identifier.issn1557-7740
dc.identifier.urihttps://hdl.handle.net/11541.2/119027
dc.language.isoen
dc.publisherMary Ann Liebert
dc.source.urihttps://doi.org/10.1089/jpm.2013.0278
dc.subjectadverse outcome
dc.subjectcancer patient
dc.subjectcancer prognosis
dc.subjectlife expectancy
dc.subjectpalliative therapy
dc.subjectprimary prevention
dc.subjectrisk assessment
dc.subjectsecondary prevention
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectCardiovascular Diseases
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectPhysician's Practice Patterns
dc.subjectFemale
dc.subjectMale
dc.titleOpportunities for deprescribing statins in patients with poor cancer prognosis
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9916071311101831

Files

Collections